Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90 per cent in high-risk adults, as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.
source https://www.cbc.ca/news/world/pfizer-antiviral-covid19-us-pill-1.6238200?cmp=rss
No comments:
Post a Comment